Indivina (Medroxyprogesterone Acetate, Estradiol Valerate)

• Indivina is a combined oral contraceptive that acts on the reproductive hormone pathway to prevent pregnancy.
• Contraception: Prevents pregnancy by inhibiting ovulation and altering cervical mucus.
• Menstrual regulation: Provides more predictable menstrual cycles and reduces dysmenorrhea.
• Acne management: Improves moderate acne through hormonal regulation.

• Medroxyprogesterone acetate binds to progesterone receptors, suppressing the luteinizing hormone surge and thereby inhibiting ovulation. Estradiol valerate provides estrogenic activity that stabilizes the endometrium, regulates the menstrual cycle, and enhances the contraceptive effect. Together, the combination also thickens cervical mucus, creating a barrier to sperm penetration, and induces endometrial changes that reduce the likelihood of implantation.

Indivina may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

• Nausea: mild stomach upset often occurring early in treatment.
• Headache: transient tension-type headaches.
• Breast tenderness: swelling or discomfort of the breasts.
• Weight gain: modest increase in body weight.
• Mood changes: irritability or emotional fluctuations.
• Spotting: irregular light bleeding between periods.

Serious or Rare Side Effects

• Thromboembolic events: deep vein thrombosis or pulmonary embolism.
• Stroke: cerebrovascular accident, especially in high‑risk individuals.
• Myocardial infarction: heart attack risk in susceptible patients.
• Severe hypertension: sudden increase in blood pressure.
• Liver disorders: jaundice or hepatic dysfunction.
• Allergic reactions: rash, itching, or anaphylaxis.

• Before prescribing Indivina, clinicians should consider several precautionary measures to ensure patient safety.
• Assess thromboembolic risk: evaluate personal and family history of clotting disorders.
• Screen for hypertension: measure blood pressure prior to initiation.
• Evaluate liver function: check hepatic enzymes in patients with liver disease.
• Counsel about smoking: advise cessation, especially in women over 35.
• Missed pill guidance: provide instructions for managing skipped doses.
• Store at ambient temperature: keep tablets in original packaging, protect from moisture and light.

Indivina can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid)

• Rifampin (potent CYP3A4 inducer) reduces contraceptive efficacy.
• St. John’s wort (herbal CYP3A4 inducer) may lower hormone levels.
• Certain antiepileptics (e.g., carbamazepine) decrease contraceptive effect.
• HIV protease inhibitors (e.g., ritonavir) may increase hormone concentrations.
• Griseofulvin (antifungal) reduces oral contraceptive effectiveness.

Moderate Interactions (Monitor Closely)

• Ketoconazole (strong CYP3A4 inhibitor) may increase hormone levels.
• Erythromycin (macrolide antibiotic) can raise plasma concentrations.
• SSRIs (e.g., fluoxetine) may affect metabolism modestly.
• NSAIDs (e.g., ibuprofen) may increase risk of hypertension.
• Diuretics (e.g., thiazides) may affect electrolyte balance.